Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes

Aeron Christopher Giles Hurt, Paul Selleck, Naomi Komadina, Robert P Shaw, Lorena Elizabeth Brown, Ian G Barr

    Research output: Contribution to journalArticleResearchpeer-review

    190 Citations (Scopus)

    Abstract

    Since 2003, highly pathogenic A(H5N]) influenza viruses have been the cause of large-scale death in poultry and the subsequent infection and death of over 140 humans. A group of 55 influenza A(H5N]) viruses isolated from various regions of South East Asia between 2004 and 2006 were tested for their susceptibility to the anti-influenza drugs the neuraminidase inhibitors and adamantanes. The majority of strains were found to be fully sensitive to the neuraminidase inhibitors oseltamivir carboxylate, zanamivir and peramivir; however two strains demonstrated increased IC50 values. Sequence analysis of these strains revealed mutations in the normally highly conserved residues 116 and 117 of the NI neuraminidase. Sequence analysis of the M2 gene showed that all of the A(H5N 1) viruses from Vietnam, Malaysia and Cambodia contained mutations (L261 and S31N) associated with resistance to the adamantane drugs (rimantadine and amantadine), while strains from Indonesia were found to be a mix of both adamantane resistant (S31N) and sensitive viruses. None of the A(H5NI) viruses from Myanmar contained mutations known to confer adamantane resistance. These results support the use of neuraminidase inhibitors as the most appropriate class of antiviral drug to prevent or treat human A(H5NI) virus infections. (c) 2006 Elsevier B.V. All rights reserved.
    Original languageEnglish
    Pages (from-to)228 - 231
    Number of pages4
    JournalAntiviral Research
    Volume73
    Issue number3
    Publication statusPublished - 2007

    Cite this